Healthcare M&A and Valuation
News and Insights

On February 17, 2026, Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI), a leading specialty diagnostics provider of pulse oximetry and patient monitoring solutions, for $180 per share in an all-cash transaction representing a total enterprise value of approximately $9.9 billion, a premium of approximately 38% to Masimo's prior closing price.

On February 2, 2026, Tenet Healthcare Corporation (NYSE: THC) announced the completion of a strategic transaction with CommonSpirit Health that returns Conifer Health Solutions to full Tenet ownership. Under the agreement, CommonSpirit will pay Tenet approximately $1.9 billion over three years, while Conifer will pay CommonSpirit approximately $540 million to redeem its 23.8% equity stake, effective January 1, 2026. The total deal value, including cash payments, balance sheet

On February 2, 2026, Medical Facilities Corporation (TSX: DR) announced the sale of its 64% interest in Oklahoma Spine Hospital, LLC (OSH) to SSM Health, a nonprofit health system, for $46 million in cash. The purchase price implies a total 100% enterprise value of approximately $71.9 million. The transaction also included the concurrent sale of Medical Facilities' 51% interest in the Surgery Center of Newport Coast, LLC to Newport Orthopedic Institute for $19.5 million.

In January 2026, General Atlantic, a leading global growth equity firm, completed its acquisition of TEAM Services Holding, Inc., one of the largest providers of Medicaid-funded personal care and consumer-directed home care services in the United States, in a transaction valued at approximately $2.76 billion. Financial details were disclosed in bond rating reports from S&P Global Ratings and Fitch Ratings published in connection with financing for the transaction.

On January 2, 2026, the University of Nebraska and Nebraska Medicine announced the completion of a historic transaction in which Clarkson, a legacy nonprofit health system, resigned its membership in Nebraska Medicine, effectively transferring its 50% governance interest to the University of Nebraska. The purchase price for Clarkson's 50% interest was $800 million, plus the assumption of outstanding debt and capital lease obligations of approximately $320.4 million as of June

On December 15, 2025, existing shareholders Kingswood Capital Management and Forager Capital Management announced they reached a definitive agreement to fully acquire Quipt Home Medical Corp., a provider of durable medical equipment, home respiratory solutions, and connected home health services. Quipt’s offerings span oxygen therapy, sleep apnea management, non-invasive ventilation, and remote patient monitoring devices, servicing patients and payors through home health age

On December 15, 2025, Cencora, Inc. (NYSE: COR) announced a definitive agreement to acquire the majority of the outstanding equity interests it does not already own in OneOncology, a physician‑led national oncology platform that empowers independent cancer care practices, from private equity firm TPG and other shareholders. The purchase price was approximately $3.6 billion in cash plus retirement of ~$1.3 billion of existing corporate debt, implying total cash consideration

On December 12 2025, Perimeter Solutions, Inc. (NYSE: PRM) entered into a definitive agreement to acquire Medical Manufacturing Technologies (MMT) from Arcline Investment Management for approximately $685 million in cash. MMT is a leading provider of highly engineered machinery, aftermarket consumables and services for the manufacturing of minimally invasive medical devices. The transaction positions Perimeter to diversify its offerings beyond its core fire‑safety and specia

On November 20, 2025, GE HealthCare announced the acquisition of Intelerad, a global provider of enterprise imaging informatics and radiology IT solutions, in a transaction that further expands GE HealthCare’s digital imaging and clinical workflow capabilities. Intelerad’s platform includes radiology information systems (RIS), picture archiving and communication systems (PACS), advanced visualization, and cloud-enabled workflow tools serving hospitals, health systems, and i

On October 29, 2025, Thermo Fisher Scientific Inc. (NYSE: TMO) announced a definitive agreement to acquire Clario Holdings, Inc., a leading global provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg, Nordic Capital, Novo Holdings and Cinven for approximately $8.875 billion in cash at closing, with additional deferred and contingent payments of up to ~$525 million tied to future performance. The transaction, subject to customary re

In October 2025, ARCHIMED Diagnostics, the diagnostics-focused arm of global healthcare investment firm ARCHIMED, completed its acquisition of a 60% majority stake in ARK Diagnostics, Inc., a Fremont, California-based developer and manufacturer of specialty in vitro diagnostic (IVD) assays and tests, from South Korean specialty chemical company Soulbrain Holdings. The transaction values ARK at approximately $428 million enterprise value, with Soulbrain retaining a 40% minorit

On October 21, 2025, Hologic, Inc., a leading global medical technology company focused on women’s health diagnostics, imaging and surgical products, agreed to be acquired by funds managed by private equity firms Blackstone and TPG in a take‑private transaction valued at up to $18.3 billion in enterprise value. Under the definitive merger agreement, Hologic stockholders will receive $76 per share in cash plus a non‑tradable contingent value right (CVR) of up to $3 per share,